The Patent Finder

Onyx Therapeutics, Inc.

24 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
11
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Combination therapy with peptide epoxyketones (US 10,596,222) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
  • 2 fees due Oct 12 to 19, 2027 · next Oct 12
  • 1 fee due Nov 12, 2027
    The maintenance fee for Tripeptide epoxy ketone protease inhibitors (US 10,647,744) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,129,346Compounds for Enzyme Inhibition
In force
 · Medium confidence
In forceMedium confidence
US 7,691,852Compounds for Enzyme Inhibition
In force
 · High confidence
In forceHigh confidence
US 8,080,545Compounds for Enzyme Inhibition
In force
 · High confidence
In forceHigh confidence
US 8,080,576Compounds for enzyme inhibition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,198,270Compounds for proteasome enzyme inhibition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,737,112Composition for enzyme inhibition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,921,324Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,921,583Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,697,837Novel Substrate for RPN 11 Enzymatic Activity
In force
 · High confidence
In forceHigh confidence
US 10,596,222Combination therapy with peptide epoxyketones
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
Also on record, not counted in the 24: 21 lapsed for an unpaid fee · 10 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 11 abandoned · 16 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited